Device Trial Radar · NCT05616104
FLEX FIRST Registry Research Protocol
Last checked: Nov 20, 2026Latest source record: Aug 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
130
Actual
Start
Nov 29, 2022
Primary completion
Feb 1, 2025
Study completion Aug 4, 2025
Sponsor
- Lead sponsor
- VentureMed Group Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 15, 2022
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective, observational study evaluating the clinical use and outcomes of the FLEX Vessel Prep (VP) system in arteriovenous fistulae or grafts presenting with clinical or hemodynamic abnormalities following 12 months post treatment.
Conditions
- Arteriovenous Fistula
- Arteriovenous Graft
- Fistula
- Arterial Occlusive Diseases
Interventions
FLEX Vessel Prep SystemDevice
The FLEX Vessel Prep System to create circumferential, continuous micro-incisions along the length of the stenosis by performing a retrograde pullback through the lesion. Following FLEX, standard balloon angioplasty is performed with an uncoated PTA balloon sized to meet the reference vessel diameter, according to its corresponding Instructions for Use. Once advanced into the lesion, the balloon should be inflated according to the site's standard of care.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Target Lesion Primary Patency RateTime frame: 6 months post procedure
1 more outcomes with a free account
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Open Access Vascular Access
Miami, Florida
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.